Galapagos' affiliate BioFocus extends collaboration with Chiesi
Advertisement
Galapagos NV announced that its BioFocus service division has expanded a collaboration with Chiesi Farmaceutici, a privately held Italian pharmaceutical company. Total value for the collaboration with Chiesi has now reached €2.5 million.
BioFocus and Chiesi began their collaboration in December 2009 and recently extended it for one year. Under the terms of the extended collaboration agreement, BioFocus will provide medicinal chemistry and biology services, with an additional option for ADME services, for an undisclosed Chiesi therapeutic program.